午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook >> journal list >> Cutis >>article
Cutis

Cutis

IF: 2.1
Download PDF

Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis.

Published:1 September 2004 DOI: PMID: 15499763
Jacques Decroix, Henrik Pres, Nicola Tsankov, Michel Poncet, Stéphanie Arsonnaud

Abstract

Owing to its anti-inflammatory, antipruritic, vasoconstrictive, and immune-modulating properties, clobetasol propionate is used to treat psoriasis. This study was conducted to evaluate the efficacy, safety, and cosmetic acceptability of clobetasol propionate lotion compared with its vehicle and with clobetasol propionate cream in the treatment of moderate to severe plaque-type psoriasis. A total of 222 patients were treated. After 4 weeks of treatment, clobetasol propionate lotion was more efficient than vehicle lotion and of equivalent efficacy as clobetasol propionate cream. Cosmetic acceptability was significantly better with clobetasol propionate lotion than with clobetasol propionate cream. Clobetasol propionate lotion was efficient, safe, and well tolerated and offers a significantly higher cosmetic advantage in the treatment of moderate to severe plaque-type psoriasis compared with clobetasol propionate cream.

Substances (1)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Clobetasol propionate 25122-46-7 C25H32ClFO5 762 suppliers $29.00-$2000.00

Similar articles

IF:4.7

Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis

Drug Design, Development and Therapy V. Di Lernia,?F. Bardazzi,etc Published: 29 January 2016